Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease

Clinical trial NCT01127633 · TERMINATED

Trial details

NCT number: NCT01127633
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2010-12-01
Primary completion: 2014-07-01
Enrollment: 1457

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.